Acme United (ACU) just posted Q2 2026 results with revenue of US$62.7 million and net income of US$5.1 million, translating into EPS of US$1.32. The company reported revenue of US$54.0 million in Q2 2025 and US$62.7 million in Q2 2026, while EPS shifted from US$1.26 to US$1.32 over the same period, giving investors fresh data points on how the top and bottom lines are tracking. With margins in focus this quarter, the results give shareholders a clearer view of how efficiently the company is turning sales into profit.

See our full analysis for Acme United.

With the quarterly scoreboard set, the next step is to see how these numbers line up against the prevailing narratives around Acme United’s growth, risks, and profitability story.

EPS Swings Highlight Acme United’s Volatility

• Q2 2026 basic EPS of US$1.32 sits alongside much lower recent quarters, including US$0.26 in Q1 2026 and US$0.49 in Q4 2025, showing that Acme United’s per share profit can move around a lot from one period to the next.
• Bulls often point to Acme United as a steady operator in everyday essentials, yet the last twelve months of EPS on a trailing basis came in at US$2.58, which contrasts with single quarters like Q1 2026 at US$0.26 and suggests that even a business built on recurring products can produce choppy earnings figures.
  • Supporters who highlight the long operating history and broad product set are met with a mixed pattern where trailing twelve month net income of US$9.8 million is spread unevenly across quarters such as US$5.1 million in Q2 2026 and under US$1.0 million in Q1 2026.
  • That tension between a “steady essentials” story and visible EPS volatility is something investors may want to keep in mind when they look past a single strong quarter.

Some investors like to cross check that choppy EPS profile with how the market values the whole story over time, rather than just reacting to one quarter.

Margins And Growth Facing Pressure

• Trailing net margin is 4.6%, down from 5.3% a year earlier, while revenue growth over the last twelve months is reported at 3.7% per year and earnings are forecast to decline about 9.2% per year over the next three years. This points to both profitability and growth expectations moving in the wrong direction together.
• Bears argue that a business built on basic school, office and first aid products has limited room to expand its economics, and the combination of a 4.6% trailing margin and a forecast 9.2% annual earnings decline gives them concrete numbers to point to.
  • Critics highlight that even with trailing revenue at about US$211.6 million, the lower margin means less profit falls to the bottom line than when margin was at 5.3%, so size alone is not offsetting the squeeze.
  • What stands out for cautious investors is that modest 3.7% revenue growth is expected to sit alongside falling earnings, which lines up closely with the bearish focus on cost pressure and limited pricing power.

Valuation Discount Versus DCF Fair Value

• At a share price of US$53.94 and a trailing P/E of 20.9x, Acme United trades below the US Medical Equipment industry average P/E of 26.4x, and also sits roughly 33.1% below a DCF fair value of about US$80.58 based on the provided estimate.
• Supporters of a more optimistic stance point to that gap to DCF fair value as potential upside, while the forecast 9.2% annual decline in earnings gives more cautious investors a clear reason to question how quickly the market might close that discount.
  • What is striking is that the 20.9x P/E is roughly in line with the 20.8x peer average, so the apparent discount is coming more from the DCF fair value of US$80.58 than from a P/E that is dramatically lower than similar companies.
  • Investors weighing the case have to consider the 33.1% gap to DCF fair value alongside the combination of 3.7% revenue growth and a lower 4.6% margin, which together make it less obvious that the current price simply reflects a mispricing rather than the earnings outlook.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Acme United's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

If the mix of risks and rewards around Acme United feels finely balanced, now is a good time to look through the details yourself and decide what matters most for your portfolio. Then weigh both sides carefully with the help of the 1 key reward and 2 important warning signs.

See What Else Is Out There Besides Acme United

Acme United combines a 4.6% trailing net margin, modest 3.7% revenue growth and expectations for earnings to decline about 9.2% per year, which may leave some investors cautious about its earnings profile.

If that mix of thin margins and pressured earnings feels uncomfortable, you can quickly compare alternatives with stronger profit potential by checking the 49 high quality undervalued stocks and seeing which stocks better fit your return targets.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.